Drug Eluting Balloon Market - Industry Analysis and Forecast (2022-2029)
FDA adcom to pronounce on paclitaxel-coated devices | Evaluate
Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions | Circulation: Cardiovascular Interventions
New MEDTRONIC ADM05004008P In.Pact Admiral Paclitaxel-Coated PTA Balloon Catheter, 5.0mm x 40mm, 80cm (X) Disposables - General For Sale - DOTmed Listing #3519528:
New MEDTRONIC In-Pact Admiral Paclitaxel-Coated PTA Balloon Catheter 4mm x 80mm x 130cm (X) ADM04008013P Disposables - General For Sale - DOTmed Listing #2847198:
US FDA approves first drug-coated balloon for treatment of in-stent restenosis - Vascular News
Drug-coated Balloon for Challenging Below-the-Knee Disease Shows Promise in Patients with Critical Limb Ischemia | DAIC
Medtronic's In.Pact 018 Drug-Coated Balloon Receives FDA Approval for PAD - Endovascular Today
Drug-coated Balloon-only Angioplasty for Native Coronary Disease Instead of Stents | ICR Journal
Medtronic to manufacture IN.PACT Admiral drug-coated balloon at new high-tech facility - Vascular News
In.Pact Falcon Drug Eluting Balloon | mcclellandesignstudio
New Data Supports Medtronic's Drug-Coated Balloon in Wake of Recall | mddionline.com
IN.PACT Admiral Drug-Coated Balloon From Medtronic Outperforms Standard Angioplasty In Landmark Study
Medtronic's IN.PACT Admiral Drug-Coated Balloon Approved To Treat Long SFA Lesions | Medical Product Outsourcing
Medtronic delivers 5-year data for its drug-coated balloon for PAD, compared to drugless angioplasty | Fierce Biotech
In.Pact Admiral Demonstrates Durability, Safety and Efficacy at Three Years | DAIC
Medtronic launches Prevail drug-coated balloon catheter in Europe - Medical Tubing and Extrusion